STRYKER - SYK NYSE
Medical Device
CNBC's Cramer - This Stock Is On Fire
Earnings Beat -Strong Buy
Stryker On Acquisition Hunt
|
Both the Medical Device Industry and
Stryker are skyrocketing . This stock is on fire says Cramer, one of
CNBC most popular commentators . Analyst (24 ) consensus is a
STRONG BUY . Rumors are that the company is very near to an
accretive acquisition .
Med Device Company Bladder Cancer Imaging The medical device industry as a whole has recently had a significant move to the upside ( See ETF Below ). Other medical device companies as well have performed well and should be considered as a core addition to your portfolio. Day Trader Alerts Serious investors should place the shares of Stryker on their long term BUY LIST. Four Biotech Stocks For 2019 Dividend Stock Yields 6.5% - Global Self Storage - REIT - NASDAQ SELF - Serious Investors STRYKER MEDICAL DEVICE ETF
Stryker Corp. (NYSE:SYK) issued fourth-quarter results Jan 29 after the closing bell. The Kalamazoo, Michigan-based medical devices producer issued non-GAAP earnings per share of $2.18 versus consensus of $2.15, GAAP earnings per share of $5.44 versus consensus of $1.8 and revenue of $3.8 billion compared to consensus for $3.74 billion. Med Device Company Pressure Biotech PBIO - Up On Volume GAAP earnings per share increased 924.2%, non-GAAP earnings per share rose 11.2% and revenue went up 9.5% year-over-year. Stryker Corp. generated $2.61 billion cash flow from its full-year 2018 operations, a 67.4% advance from 2017. The company has also produced non-GAAP earnings per share of $1.8 to $1.85 for the first trimester and of $8 to $8.2 for full-year 2019. Regarding the top line of the income statement for full fiscal 2019, Stryker Corp. forecasts that total revenues will grow at a 6.5-7.5% rate from 2018. Louis Navellier Top 10 Stocks For 2019 The share price has decreased 2% to $161.1 for the 52 weeks through Jan. 29 and is now trading below the 200-, 100- and 50-day simple moving average lines. The 52-week range is $144.75 to $179.84. The market capitalization of the stock is approximately $60.27 billion. The stock has a price-book ratio of 6.11 versus an industry median of 3.06, a price-earnings ratio of 49.71 versus an industry median of 30.17 and a price-sales ratio of 4.62 versus an industry median of 3.15. Marijuana Stock On Fire Up 60 % in 60 Days Canopy Growth (CGC NYSE ) Get Report The stock has a forward dividend yield of 1.29% compared to an industry median of 1.48%. GuruFocus has assigned to Stryker Corp. a financial strength rating of 6 out of 10 and a profitability and growth rating of 8 out of 10. Stryker was founded in the early 1940s by Dr. Homer Stryker, in large part because he felt that the medical device industry was falling short of meeting his patients’ needs. He wanted to design products that would help improve their lives. Today, Stryker is a worldwide leader in orthopedic implants, surgical equipment and neurovascular products. The company produces more than $12 billion in annual sales and has a current market cap of nearly $59 billion.About WallStreetResearcher.com : WallStreetResearcher.com is a subsidiary of Target Publishing Inc, and is a leading publisher of todays market and investment news, commentary, proprietary research and videos from seasoned journalists, analysts and contributors covering the financial markets and global economies. Leveraging our extensive distribution network and social media presence, we have cultivated a valuable audience of engaged market enthusiasts, which in turn delivers a variety of unique opportunXities for industry partnerships, corporate communications, market exposure and investment. The article does not constitute investment advice. Each reader is encouraged to consult with his or her individual financial professional and any action a reader takes as a result of information presented here is his or her own responsibility |